Real-time enrollment status for this non-small cell lung cancer clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT05785767 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Non-Small Cell Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 850 participants |
| Active Locations | 27 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | January 22, 2026 (Jan 22, 2026) |
As of March 2, 2026: Clinical trial NCT05785767 is currently active_not_recruiting participants. This clinical trial study for non-small cell lung cancer is not currently accepting new participants at 27 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05785767 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 27 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05785767 was last updated Jan 22, 2026 (January 22, 2026). HelloStudys verifies this status automatically.